These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14525783)

  • 1. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.
    Godfrey WR; Krampf MR; Taylor PA; Blazar BR
    Blood; 2004 Feb; 103(3):1158-65. PubMed ID: 14525783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival.
    Watson D; Zhang GY; Sartor M; Alexander SI
    J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
    Hartwig UF; Robbers M; Wickenhauser C; Huber C
    Blood; 2002 Apr; 99(8):3041-9. PubMed ID: 11929798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
    Wehler TC; Nonn M; Brandt B; Britten CM; Gröne M; Todorova M; Link I; Khan SA; Meyer RG; Huber C; Hartwig UF; Herr W
    Blood; 2007 Jan; 109(1):365-73. PubMed ID: 16931626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.
    Davies JK; Barbon CM; Voskertchian AR; Nadler LM; Guinan EC
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro.
    Nikolaeva N; Uss E; van Leeuwen EM; van Lier RA; ten Berge IJ
    Transplantation; 2004 Sep; 78(6):815-24. PubMed ID: 15385799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomagnetic selective donor-derived CD4
    Varlet P; Rogeau S; Trauet J; Demaret J; Labalette M
    Curr Res Transl Med; 2019 Feb; 67(1):1-7. PubMed ID: 30665880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.
    Koh MB; Prentice HG; Lowdell MW
    Bone Marrow Transplant; 1999 May; 23(10):1071-9. PubMed ID: 10373075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK; Koh MB; Lowdell MW
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
    Amrolia PJ; Muccioli-Casadei G; Yvon E; Huls H; Sili U; Wieder ED; Bollard C; Michalek J; Ghetie V; Heslop HE; Molldrem JJ; Rooney CM; Schlinder J; Vitetta E; Brenner MK
    Blood; 2003 Sep; 102(6):2292-9. PubMed ID: 12763937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment.
    Koh MB; Prentice HG; Corbo M; Morgan M; Cotter FE; Lowdell MW
    Br J Haematol; 2002 Jul; 118(1):108-16. PubMed ID: 12100133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.
    Scheinberg P; Price DA; Ambrozak DR; Barrett AJ; Douek DC
    Exp Hematol; 2006 Jun; 34(6):788-95. PubMed ID: 16728284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use.
    Albon SJ; Mancao C; Gilmour K; White G; Ricciardelli I; Brewin J; Lugthart G; Wallace R; Amrolia PJ
    Cytotherapy; 2013 Jan; 15(1):109-21. PubMed ID: 23260091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69).
    Fehse B; Frerk O; Goldmann M; Bulduk M; Zander AR
    Br J Haematol; 2000 Jun; 109(3):644-51. PubMed ID: 10886218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of alloreactive donor T cells using immunomagnetic cell selection.
    Fehse B; Goldmann M; Frerk O; Bulduk M; Zander AR
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S39-42. PubMed ID: 10933186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function.
    Chen ZM; O'Shaughnessy MJ; Gramaglia I; Panoskaltsis-Mortari A; Murphy WJ; Narula S; Roncarolo MG; Blazar BR
    Blood; 2003 Jun; 101(12):5076-83. PubMed ID: 12609834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
    Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
    J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.
    Ge X; Brown J; Sykes M; Boussiotis VA
    Biol Blood Marrow Transplant; 2008 May; 14(5):518-30. PubMed ID: 18410894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.